Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Tremfya (guselkumab)
Marketing
AbbVie’s Skyrizi leading drug in pharma’s ad spending league
AbbVie retook the top spot from rival J&J and its immunology drug Tremfya in July’s top TV drug ad spending rankings.
Ben Adams
Aug 7, 2026 9:45am
With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter
Jul 31, 2026 11:18am
J&J’s Tremfya remains on top in Q2 pharma ad spending league
Jul 21, 2026 9:10am
J&J's immunology portfolio compensates for Stelara's LOE
Jul 15, 2026 11:30am
AbbVie's Skyrizi nabs May's top ad spending spot over Tremfya
Jun 9, 2026 3:33pm
AbbVie’s Skyrizi retakes top spot in April ad spend rankings
May 8, 2026 10:03am
